Description
NSI-189
NSI-189 is an investigational small molecule studied for its potential effects on neurogenesis and neurological function. It has been evaluated in clinical research involving major depressive disorder, but results have been mixed. It is not an approved treatment for depression or cognitive impairment.
How It Works
NSI-189 was developed around the hypothesis that influencing neurogenesis and related cellular processes might affect mood and cognition. Its precise mechanism remains incompletely understood, and proposed neurogenic effects should not be treated as proof of clinical benefit.
POTENTIAL RESEARCH INTEREST
- Neurogenesis research: Investigated for potential effects on processes associated with neuron development.
- Mood-related research: Evaluated in clinical trials involving major depressive disorder.
- Cognitive measures: Studied using selected cognitive and self-reported outcome measures.
- Mechanism research: Remains a subject of investigation because its pharmacological action is not fully established.
Side Effects and Safety
Clinical trials have provided preliminary tolerability information, but they do not establish the safety or effectiveness of NSI-189 for general use. The evidence is insufficient to recommend it as a treatment for depression or cognitive symptoms.
Dosage
No approved human-use dosage is established for NSI-189. Doses used in clinical trials are study-specific and are not instructions for self-administration.
Handling & Safety
Confirm the identity and form of the compound, including whether the material is supplied as a phosphate salt. Follow appropriate laboratory procedures.
Where to Find NSI-189
IML provides research information and links to independent suppliers. The selected supplier handles product sales and fulfillment.
Affiliate Disclosure: IronMountainLabz does not sell or ship NSI-189. Links on this page may direct readers to independent suppliers through affiliate links.
